Last updated: March 23, 2012
Bethesda, Md., Feb. 9, 2011 — A new strategic plan from an arm of the National Institutes of Health envisions scientists being able to identify genetic bases of most single-gene disorders and gaining new insights into multi-gene disorders in the next decade. This should lead to more accurate diagnoses, new drug targets and the development of practical treatments for many who today lack therapeutic options, according to the plan from the National Human Genome Research Institute (NHGRI).
On February 10, 2011, Nature magazine published the National Human Genome Research Institute's (NHGRI) strategic plan for the future of human genome research called Charting a course for genomic medicine from base pairs to bedside. This strategic vision was developed in consultation with leading genome researchers over more than two years and is intended to inspire many to contribute to advancing genomic understanding, especially as other National Institutes of Health (NIH) institutes and centers focus genomic technologies on the diseases they study.
To celebrate the 10th anniversary of the first analysis of the draft human genome, and the launch of the new strategic vision for the field of genomics, NHGRI sponsored a symposium with leading thinkers in the field of genome research - including all three directors in the history of the National Human Genome Research Institute - who gathered on the campus of the National Institutes of Health on February 11, 2011, to consider the future of their field.
Follow the links below to the full strategic plan, symposium information, the planning process that developed the plan and related information.
- Strategic Plan: Charting a course for genomic medicine from base pairs to bedside
February 10, 2011
- Symposium: A Decade with the Human Genome Sequence: Charting a Course for Genomic Medicine
- Strategic Plan Press Release: NHGRI charts course for the next phase of genomics research